Navigation Links
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
Date:5/16/2008

urities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date on which it was made.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
2. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
3. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
4. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
5. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
8. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
9. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
10. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25 Heska Corporation ( H...diagnostic and specialty products to the veterinar...Diagnostics Corporation for the supply of blood ga...rinary market. ,, (Logo: http://www.newsco...ka and Roche share the same passion for innovating...
(Date:11/25/2009)...-BioTrendsResearchGroup,Inc.releasedWave1ofits La...i-phasesyndicatedmarketresearchprojecttrackingthel...aunchthroughthefirstsixmonthsofavailability.Eachwa...uniqueDermatologistsandqualitativeinformationfroma...staclestouse,typicalpatienttypes,productperception...
(Date:11/25/2009).... 25 Regado Biosciences, a private...ombotic aptamers with active control agents, annou...l be presenting at the Piper Jaffray 21st Annual H... in New York City. Dr. Mazzo,s presentation will ...d will include an overview of the Company,s pipeli...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Study to Investigate AHCC and the Swine Flu Virus 47555 1Study to Investigate AHCC and the Swine Flu Virus 47555 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4
...lly relevant model of,normal human skin found that...g the cytotoxic effect of erlotinib * Phase I sing...generally well,tolerated in metastatic melanoma pa...nventional vincristine , SOUTH SAN FRANCISCO, Cali...ces (Nasdaq:HNAB), a biopharmaceutical company foc...
... – Genta,Incorporated (Nasdaq: GNTA) announc...ical trial of its marketed product, Ganite®,(g...®;,Genentech/IDEC) and dexamethasone in patien... lymphoma (NHL). The data were,presented at the an...ncology (ASCO) in Chicago, IL. , ,Previously publi...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ission Includes Clinical Data Demonstrating Superi...R) Drug Eluting Stent, TOKYO, June 2 Abbott (NYS... application for Seizo Hanbai Shonin,(Marketing Au...its XIENCE(TM) V Everolimus Eluting Coronary Stent...
..., June 2 Treating pancreatic cancer with a combin... prior to surgery is safe and may be beneficial fo...h Cancer Institute (UPCI) study presented at the 4...nter of the University of Pittsburgh Medical Cente...
..., Ill., June 2 With all the concerns about,what,s...even more attention,these days to what we are givi...ng a few precautions. After all, pet,food recalls ...cording to a study in the June 1, 2008, Journal of...
..., June 2 Kensey Nash Corporation,(Nasdaq: KNSY )...sale of its,endovascular business to Spectranetics... 30, 2008. This transaction includes the sale of t...ts of the Kensey Nash and Spectranectics transitio...
...dney Care Provider Recognized by the Association o... Inspiring Tales of Patient and Teammate ...., June 2 DaVita Inc., a leading,provider of kidn...gazine: Stories from the Village, received two,pre...
...BUS, Ohio) Bunk bed-related injuries are not an i...en according to a study conducted by investigators...he Research Institute at Nationwide Childrens Hosp...unger than 10 years of age, there is a surprising ...
Other Medicine News:Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:New treatment combination safe for pancreatic cancer patients 2Health News:Is Tap Water Safe for Your Dog? 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 3Health News:DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards 2Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3
Acuvue Toric
Binocular Loupes
Near Functional Acuity - Fact101
Near Point Card/Newspaper 8 to 48 - BC2203
Medicine Products: